Summary
This narrative review examines the immunomodulatory properties of probiotics and their derived bioactive compounds—particularly bacteriocins and short-chain fatty acids—as therapeutic agents for inflammatory and autoimmune diseases. The authors synthesise evidence on how these compounds modulate gut microbiota, suppress inflammatory responses, and enhance immune cell function to maintain intestinal homeostasis. The paper addresses both underlying mechanisms and practical challenges in administering such interventions to patients.
UK applicability
The immunological mechanisms described are relevant to UK clinical and public health contexts, particularly for managing inflammatory bowel disease and autoimmune conditions. Applicability to dietary or agricultural practice in the UK would depend on the specific food sources and delivery methods discussed in the full paper.
Key measures
Immunological markers of inflammation; microbial diversity and composition; immune cell function; mechanisms of gut homeostasis regulation
Outcomes reported
This review synthesises evidence on how probiotics, bacteriocins, and short-chain fatty acids modulate immune function and gut microbiota composition. The paper examines mechanisms by which these bioactive compounds suppress inflammation and restore microbial diversity in pathological states.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.